Rheumatoid arthritis and genetic variations in cytokine genes: A population-based study in Kashmir Valley

Immunological Investigations

Volumn 43, Issue 4, 2014, Pages 349-359

  Shafia, Syed ^a   Dilafroze, ^a   Sofi, Fayaz A ^a   Rasool, Roohi ^a   Javeed, Sheikh ^a   Shah, Zafar Amin ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Interleukin; Kashmir; Polymorphism; RFLP; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; CYTOKINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INDIA; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; AGED; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898014235     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.879171     Document Type: Article

References (37)

1. Abbot SE, Kaul A, Stevens CR, Blake DR. (1992). Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression. Arthritis Rheum, 35, 401-6.
2. Aletaha D, Neogi T, Silman AJ, et al. (2010). Rheumatoid arthritis classification criteria. Arthritis Rheumat, 62, 2569-81. DOI 10.1002/art.27584.
3. Arend WP. (2002). The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev, 13, 323-40.
4. Barton A, Worthington J. (2009). Genetic susceptibility to rheumatoid arthritis: An emerging picture. Arthritis Rheum, 61, 1441-6.
5. Bresnihan B, Cobby M. (2003). Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford), 42, ii22-8. [PubMed: 12817092]. (Pubitemid 37220897)
6. Buchs N, di Giovine FS, Silvestri T, et al. (2001). IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: Interaction with their plasma levels. Genes Immun, 2, 222-228. (Pubitemid 33676987)
7. Chung SJ, Kwon YJ, Park MC, et al. (2011). The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients. Yonsei Med J, 52, 113-20.
8. Cox A, Camp NJ, Cannings C, et al. (1999). Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet, 8, 1707-1713. (Pubitemid 29423880)
9. Dayer JM. (2003). The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford), 42, ii3-10. [PubMed: 12817089].
10. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. (1989). The contribution of HLA to rheumatoid arthritis. Clin Genet, 36, 178-82. (Pubitemid 19218460)
11. Dieude P. (2009). Rheumatic diseases: Environment and genetics. Joint Bone Spine, 76, 602-7.
12. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. (1992). Single base polymorphism at-511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet, 1, 450.
13. Fabris M, Quartuccio L, Lombardi S, et al. (2010). Study on the possible role of the-174G/C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis. Reumatismo, 62, 253-8.
14. Fishman D, Faulds G, Jeffery R, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102(7), 1369-76. (Pubitemid 28467565)
15. Feldmann M, Brennan FM, Maini RN. (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol, 14, 397-440. (Pubitemid 26130190)
16. Firestein GS, Alvaro-Gracia JM, Maki R. (1990). Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol, 144, 3347.
17. Fishman D, Faulds G, Jeffery R, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369-76. (Pubitemid 28467565)
18. FitzGerald O, Soden M, Yanni G, et al. (1991). Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis, 50, 792-6.
19. Fonseca JE, Santos MJ, Canha OH, Choy E. (2009). Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev, 8, 538-42.
20. Guerne PA, Zuraw BL, Vaughan JH, et al. (1989). Synovium as a source of interleukin 6 in vitro: Contribution to local and systemic manifestations of arthritis. J Clin Invest, 83, 583-585.
21. Hall SK, Perregaux DG, Gabel CA, et al. (2004). Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum, 50, 1976-83. (Pubitemid 38725110)
22. Horai R, Saijo S, Tanioka H, et al. (2000). Development of chronic inflammatory arthropathy resembeling rheumatoid arthritis in interleukin-1 receptor antagonist-deficient mice. J Exp Med, 191, 313-20. (Pubitemid 30060920)
23. Iguchi T, Ziff M. (1986). Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest, 77, 355-61. (Pubitemid 16037632)
24. Kishimoto T (2005). Interleukin-6: From basic science to medicine-40 years in immunology. Annu Rev Immunol, 23, 1-21. (Pubitemid 40563163)
25. Lawrence JS. (1961). Prevalence of rheumatoid arthritis. Ann Rheum Dis, 20, 11-7.
26. Lee YH, Bae SC, Choi SJ, et al. (2012). The association between interleukin-6 polymorphisms and rheumatoid arthritis: A meta-analysis. Inflamm Res, 61, 665-71.
27. Lubbe S, Tikly M, van der Merwe L, et al. (2008). Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis. Joint Bone Spine, 75, 422-5.
28. Malaviya AN, Kapoor S, Singh RR, et al. (1993). Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int, 13, 131-4. (Pubitemid 24018727)
29. Marinou I, Healy J, Mewar D, et al. (2007). Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum, 56, 2549-56. (Pubitemid 47237273)
30. Pawlik A, Wrzesniewska J, Florczak M, et al. (2005). IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol, 34, 109-13. (Pubitemid 40694829)
31. Pincus T. (1995). Long-term outcomes in rheumatoid arthritis. Br J Rheumatol, 34, 59-73. (Pubitemid 26013492)
32. Pocoit F, Molvig J, Wogensel L, et al. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest, 22, 396-402.
33. Postlethwaite AE, Lachman LB, Kang AH. (1984). Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells. Arthritis Rheum, 27, 995.
34. Sawada T, Hirohata S, Inoue T, Ito K. (1991). Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis. Clin Exp Rheumatol, 9, 363-8.
35. van de Loo FA, Joosten LA, van Lent PL, et al. (1995). Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen-and zymosan-induced arthritis. Arthritis Rheum, 38, 164-72.
36. Wilson AG, Symons JA, McDowell TL, et al. (1997). Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA, 94, 3195-9. (Pubitemid 27157287)
37. Zhang X, Llamado L, Pillay I, et al. (2002). Interleukin-1 gene polymorphism disease activity and bone mineral metabolism in rheumatoid arthritis. Chin Med J (Engl.), 115, 46-9. (Pubitemid 34130434)